US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

plane exhaust in a downward spiral shape
The FDA could see budget authority dollars reduced for a second straight year. • Source: Shutterstock

The US Food and Drug Administration may be headed for a second straight year of cuts to its non-user fee funding, a move that could hamper its ability to handle increasing salary obligations, complete a major reorganization, and adapt to expensive new technology like artificial intelligence.

Key Takeaways

  • The House subcommittee bill would cut the FDA's non-user fee funding for the second consecutive year.

The House Appropriations Agriculture, Rural Development and FDA Subcommittee advanced a fiscal year 2025 funding bill via voice vote...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet